扩髓带锁髓内针治疗胫腓骨骨折

回顾分析经扩髓带锁髓内针治疗的38例胫腓骨骨折的疗效；最终结果采用Jouner-Wruh评分标准评定，平均随访14．6（6－32）个月。结果：经扩髓带锁内针治疗胫腓骨骨折，优33例，良4例，中1例。无锁定螺钉和髓内针折断，无腓总神经损伤，无深部感染和畸形愈合。扩髓带锁髓内针在治疗胫腓骨骨折中既能起到稳定可靠的固定作用，又能减少骨折局部软组织及血运的破坏，有利于骨折的愈合及患肢功能的康复。

Reamed interlocking intramedullary nail in the treatment of tibial and fibular fractures]

To analyse retrospectively the results of thirty-eight fractures of the tibial and fibular treated with reamedintramedullary interlocking nail from May 1997 to June 2000. The patients were followed for an average of 14.6(range: 6-32) months. The mean age was 32.8(range: 18-64) years, the sex distribution was 29 males and 9 females. 26 fractures were closed (One case was failure of plate and screws) and 12 were opened: 6 were graded I, 4 were II, 2 IIIa, according to Gustilo's classification. A solid union was achieved in all patients within a period of 6 months. There were no deep infections except one case of superficial infection. Cases of deformity or peroneal nerve injury were no noticed. It is believed that reamed intramedullary interlocking nail allows a stable and safety fixation in open or closed tibial and fibular fractures.